RHUMBLINE ADVISERS

Position in AMRN — Amarin Corp Plc\Uk

CIK 1115418 BOSTON, MA

Position in AMRN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$59,504

+$11,223 QoQ

Shares Held

3,733

+11.8% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#40

of 80 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. AMRN ranks #16 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,333,307	$1,599,208,548
2	JNJ	Johnson & Johnson	3,780,752	$960,197,585
3	ABBV	AbbVie Inc.	2,733,648	$687,895,182
4	MRK	Merck & Co., Inc.	3,809,518	$489,523,063
5	AMGN	Amgen Inc	904,954	$327,701,942
6	GILD	Gilead Sciences, Inc.	2,051,819	$259,226,812
7	PFE	Pfizer Inc	8,609,603	$207,319,240
8	BMY	Bristol Myers Squibb Co	3,347,347	$192,874,134

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$59,504	3,733	+11.8%	Shares	Sole	2026-08-12
2026-03-31	$48,281	3,339	+9.8%	Shares	Sole	2026-05-12
2025-12-31	$42,438	3,040	+130.3%	Shares	Sole	2026-02-13
2025-09-30	$21,621	1,320	+4.6%	Shares	Sole	2025-11-06
2025-06-30	$20,469	1,262	-95.0%	Shares	Sole	2025-08-12
2025-03-31	$11,380	25,290	-2.3%	Shares	Sole	2025-05-29
2024-12-31	$12,689	25,896	+156.8%	Shares	Sole	2025-05-29
2024-09-30	$6,354	10,086	+33.7%	Shares	Sole	2024-11-12
2024-06-30	$5,206	7,546	-4.6%	Shares	Sole	2024-08-01
2024-03-31	$7,043	7,914	+91.3%	Shares	Sole	2024-05-09
2023-12-31	$3,600	4,138	+157.8%	Shares	Sole	2024-02-08
2023-09-30	$1,476	1,605	+14.6%	Shares	Sole	2023-11-09
2023-06-30	$1,666	1,400	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.